These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13364151)

  • 21. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein.
    Courtney HS; Hasty DL; Dale JB
    Mol Microbiol; 2006 Feb; 59(3):936-47. PubMed ID: 16420362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reactivity of rabbits in chronic streptococcal infection].
    Toshkov A; Zhelev V; Shirova L; Obretenova K; Radeva M
    Izv Mikrobiol Inst (Sofiia); 1970; 21():131-41. PubMed ID: 4948932
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of group and type-specific antisera for the typing of streptococcal infections in Mexico].
    Giono-Cerezo S; Girón-Ortiz J; Aguirre-Langle E; Escamilla-Avilés E
    Bol Med Hosp Infant Mex; 1986 Aug; 43(8):470-7. PubMed ID: 3530276
    [No Abstract]   [Full Text] [Related]  

  • 24. Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
    Whitnack E; Dale JB; Beachey EH
    Trans Assoc Am Physicians; 1983; 96():197-202. PubMed ID: 6208666
    [No Abstract]   [Full Text] [Related]  

  • 25. Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice.
    Kawabata S; Kunitomo E; Terao Y; Nakagawa I; Kikuchi K; Totsuka K; Hamada S
    Infect Immun; 2001 Feb; 69(2):924-30. PubMed ID: 11159987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of group A streptococcal cervical lymphadenitis in mice.
    GLASER RJ; BERRY JW; LOEB LH
    Proc Soc Exp Biol Med; 1953 Jan; 82(1):87-92. PubMed ID: 13037811
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility of inbred mice to group A streptococcal infection.
    MURPHY WH; WATSON DW
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):755-8. PubMed ID: 13431945
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.
    Mansour NM; Abdelaziz SA
    Microbiol Immunol; 2016 Aug; 60(8):527-32. PubMed ID: 27301486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental studies on initial focus of invasion of group A streptococci. 2. Aerosol infection with group A streptococci in rabbits].
    Hokonohara M; Baba Y; Yoshinaga M; Kawakami K; Inoue H; Jitousho T; Maeda S; Terawaki T
    Kansenshogaku Zasshi; 1985 Aug; 59(8):793-8. PubMed ID: 3937870
    [No Abstract]   [Full Text] [Related]  

  • 30. Promotion of phagocytosis of Streptococcus pyogenes in human blood by a fibrinogen-binding peptide.
    Li Y; Courtney HS
    Microbes Infect; 2011 Apr; 13(4):413-8. PubMed ID: 21241819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotactic activity of polymorphonuclear leukocytes to Streptococcus pyogenes.
    Tylewska S; Kłosińska-Kita E; Malinowski W
    Zentralbl Bakteriol Orig A; 1978 Sep; 241(3):294-300. PubMed ID: 364883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen.
    Noursadeghi M; Bickerstaff MC; Gallimore JR; Herbert J; Cohen J; Pepys MB
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14584-9. PubMed ID: 11121061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe invasive streptococcal infection by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis.
    Watanabe S; Takemoto N; Ogura K; Miyoshi-Akiyama T
    Microbiol Immunol; 2016 Jan; 60(1):1-9. PubMed ID: 26762200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of fraction of mechanically disrupted cells for production of group A Streptococcus typing antisera.
    CONROY E; UPDYKE EL
    Science; 1954 Jan; 119(3080):69-70. PubMed ID: 13122029
    [No Abstract]   [Full Text] [Related]  

  • 38. Annihilating host defense.
    Frank MM
    Nat Med; 2001 Dec; 7(12):1285-6. PubMed ID: 11726964
    [No Abstract]   [Full Text] [Related]  

  • 39. [OF- and anti-OF test systems in microbiological and epidemiologic practice].
    Beliakova IV; Totolian AA
    Vestn Akad Med Nauk SSSR; 1989; (11):54-9. PubMed ID: 2483011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the effectiveness of penicillin-prophylaxis in experimental infections in mice with Staphylococcus aureus and Streptococcus pyogenes.
    Oosterhuis CJ
    Arch Chir Neerl; 1966; 18(3):221-31. PubMed ID: 4226217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.